ANGIODYNAMICS INC — Form 10-K/A
Filed September 29, 2026 · analyzed by the Periodic Agent
10-K/A
— Neutral
significance 28/100
What the filing says
AngioDynamics Inc (market cap ~$436M) filed a 10-K/A (amended annual report) for fiscal year ended May 31, 2026 on September 29, 2026. The filing document does not contain substantive disclosure of what was amended, the dollar amounts affected, or the nature of the restatement in the text provided. Standard SEC exhibits (certifications, XBRL data files) are present but amendment specifics are absent.
Why this rating
Amendment filed but no quantified restatement details disclosed here; cannot assess materiality without specifics. Routine amended filing mechanics.
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.